journal article·2021-10

Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery Applications

Shayna Sharma, Mostafa Kamal Masud, Yusuf Valentino Kaneti, Prarthana Rewatkar, Aayushi Koradia, Md. Shahriar A. Hossain, Yusuke Yamauchi, Amirali Popat, Carlos Salomon

Small· Volume 17· Issue 42
Publisher page

Abstract

Abstract Extracellular vesicles (EVs) can transfer intercellular messages in various (patho)physiological processes and transport biomolecules to recipient cells. EVs possess the capacity to evade the immune system and remain stable over long periods, identifying them as natural carriers for drugs and biologics. However, the challenges associated with EVs isolation, heterogeneity, coexistence with homologous biomolecules, and lack of site‐specific delivery, have impeded their potential. In recent years, the amalgamation of EVs with rationally engineered nanostructures has been proposed for achieving effective drug loading and site‐specific delivery. With the advancement of nanotechnology and nanoarchitectonics, different nanostructures with tunable size, shapes, and surface properties can be integrated with EVs for drug loading, target binding, efficient delivery, and therapeutics. Such integration may enable improved cellular targeting and the protection of encapsulated drugs for enhanced and specific delivery to target cells. This review summarizes the recent development of nanostructure amalgamated EVs for drug delivery, therapeutics, and real‐time monitoring of disease progression. With a specific focus on the exosomal cargo, diverse drug delivery system, and biomimetic nanostructures based on EVs for selective drug delivery, this review also chronicles the needs and challenges of EV‐based biomimetic nanostructures and provides a future outlook on the strategies posed.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Exosome Biology Laboratory UQ Centre for Clinical Research Royal Brisbane and Women's Hospital The University of Queensland Herston Brisbane City QLD 4029 Australia

Australian Institute for Bioengineering and Nanotechnology (AIBN) The University of Queensland Brisbane QLD 4072 Australia

JST‐ERATO Yamauchi Materials Space‐Tectonics Project and International Center for Materials Nanoarchitectonics (WPI‐MANA) National Institute for Materials Science Tsukuba Ibaraki 305‐0044 Japan

Department of Biochemistry and Molecular Biology School of Life Sciences Shahjalal University of Science & Technology Sylhet 3114 Bangladesh

School of Pharmacy The University of Queensland Woolloongabba, Brisbane QLD 4102 Australia

School of Mechanical and Mining Engineering Faculty of Engineering Architecture and Information Technology (EAIT) The University of Queensland Brisbane QLD 4072 Australia

Mater Research Institute—The University of Queensland and Translational Research Institute Woolloongabba, Brisbane QLD 4102 Australia

Faculty of Health Sciences University of Queensland Building 71/918, Royal Brisbane Hospital, Herston Brisbane QLD 4029 Australia

Funding

National Health and Medical Research Council · Ovarian Cancer Research Foundation · Exploratory Research for Advanced Technology

References (100+)

Show source-provided references
1. 10.1016/j.blre.2012.12.00210.1016/j.blre.2012.12.002 ↗
2. 10.1083/jcb.20121113810.1083/jcb.201211138 ↗
3. 10.1038/nrm.2017.12510.1038/nrm.2017.125 ↗
4. 10.3389/fgene.2020.0070010.3389/fgene.2020.00700 ↗
5. 10.1016/j.gpb.2017.03.00610.1016/j.gpb.2017.03.006 ↗
6. 10.1007/s00467-017-3816-z10.1007/s00467-017-3816-z ↗
7. 10.1111/jcmm.1347910.1111/jcmm.13479 ↗
8. 10.1021/acs.analchem.8b0361910.1021/acs.analchem.8b03619 ↗
9. 10.3390/cells807072710.3390/cells8070727 ↗
10. 10.1038/cdd.2008.16810.1038/cdd.2008.168 ↗
11. 10.1186/s13578-019-0282-210.1186/s13578-019-0282-2 ↗
12. 10.1021/acs.accounts.9b0010910.1021/acs.accounts.9b00109 ↗
13. He X. · Front. Mol. Biosci. · 2021 · 8 · 19
14. 10.1016/j.cmet.2019.07.01110.1016/j.cmet.2019.07.011 ↗
15. 10.1038/s41392-020-00261-010.1038/s41392-020-00261-0 ↗
16. 10.3390/pharmaceutics1004021810.3390/pharmaceutics10040218 ↗
17. 10.1039/C9CS00174C10.1039/C9CS00174C ↗
18. 10.1039/C5MH00012B10.1039/C5MH00012B ↗
19. 10.1246/bcsj.2018036810.1246/bcsj.20180368 ↗
20. 10.1039/C6QM00240D10.1039/C6QM00240D ↗
21. 10.1002/advs.20200129410.1002/advs.202001294 ↗
22. 10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
23. 10.1517/1742524090357997110.1517/17425240903579971 ↗
24. 10.3390/cancers1112197910.3390/cancers11121979 ↗
25. 10.1016/j.nantod.2014.04.00810.1016/j.nantod.2014.04.008 ↗
26. 10.1038/s41578-020-00277-610.1038/s41578-020-00277-6 ↗
27. 10.1038/d41586-020-01769-910.1038/d41586-020-01769-9 ↗
28. 10.1016/j.addr.2020.04.00410.1016/j.addr.2020.04.004 ↗
29. 10.4155/fmc-2020-011710.4155/fmc-2020-0117 ↗
30. 10.2147/IJN.S59610.2147/IJN.S596 ↗
31. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
32. 10.1016/j.cocis.2020.10141210.1016/j.cocis.2020.101412 ↗
33. 10.1242/jcs.12886810.1242/jcs.128868 ↗
34. 10.1038/nature0884910.1038/nature08849 ↗
35. 10.1038/nrm293710.1038/nrm2937 ↗
36. 10.3389/fimmu.2014.0044210.3389/fimmu.2014.00442 ↗
37. 10.1016/j.semcdb.2014.03.03410.1016/j.semcdb.2014.03.034 ↗
38. 10.1083/jcb.20190411310.1083/jcb.201904113 ↗
39. 10.1038/ncomms447710.1038/ncomms4477 ↗
40. 10.1038/ncb250210.1038/ncb2502 ↗
41. 10.1038/cr.2015.2910.1038/cr.2015.29 ↗
42. 10.1074/jbc.C112.44456210.1074/jbc.C112.444562 ↗
43. 10.3389/fimmu.2020.0094810.3389/fimmu.2020.00948 ↗
44. 10.1007/s00018-017-2690-y10.1007/s00018-017-2690-y ↗
45. 10.1038/s41467-018-06197-y10.1038/s41467-018-06197-y ↗
46. 10.1093/nar/gks65810.1093/nar/gks658 ↗
47. 10.1186/s12943-019-0984-410.1186/s12943-019-0984-4 ↗
48. 10.1016/j.canlet.2020.01.03310.1016/j.canlet.2020.01.033 ↗
49. 10.1098/rstb.2013.050210.1098/rstb.2013.0502 ↗
50. 10.1371/journal.pone.021067510.1371/journal.pone.0210675 ↗
51. 10.1016/j.ajog.2015.07.00110.1016/j.ajog.2015.07.001 ↗
52. 10.1080/20013078.2019.165059510.1080/20013078.2019.1650595 ↗
53. 10.3390/cells802016610.3390/cells8020166 ↗
54. 10.1186/1471-2164-13-35710.1186/1471-2164-13-357 ↗
55. 10.1002/smtd.20170013110.1002/smtd.201700131 ↗
56. 10.1038/ncb192910.1038/ncb1929 ↗
57. 10.1038/ncomms128510.1038/ncomms1285 ↗
58. 10.1038/ncomms398010.1038/ncomms3980 ↗
59. 10.7554/eLife.1927610.7554/eLife.19276 ↗
60. 10.1016/j.celrep.2016.09.03110.1016/j.celrep.2016.09.031 ↗
61. 10.1371/journal.pone.019596910.1371/journal.pone.0195969 ↗
62. 10.1038/s41580-020-0251-y10.1038/s41580-020-0251-y ↗
63. 10.1038/aps.2017.1210.1038/aps.2017.12 ↗
64. 10.1063/1.508712210.1063/1.5087122 ↗
65. 10.1080/10717544.2020.174875810.1080/10717544.2020.1748758 ↗
66. 10.1042/BST035004110.1042/BST0350041 ↗
67. 10.1016/j.apsb.2019.08.00310.1016/j.apsb.2019.08.003 ↗
68. 10.1016/j.ijpharm.2018.03.02110.1016/j.ijpharm.2018.03.021 ↗
69. 10.1007/s13346-020-00743-210.1007/s13346-020-00743-2 ↗
70. 10.1016/j.jconrel.2020.07.02110.1016/j.jconrel.2020.07.021 ↗
71. 10.1038/s41598-020-71396-x10.1038/s41598-020-71396-x ↗
72. 10.2217/nnm.12.16010.2217/nnm.12.160 ↗
73. 10.1021/mp500389v10.1021/mp500389v ↗
74. 10.1016/B978-0-12-818038-9.00005-310.1016/B978-0-12-818038-9.00005-3 ↗
75. 10.1016/j.addr.2021.01.01210.1016/j.addr.2021.01.012 ↗
76. 10.1002/btm2.1014310.1002/btm2.10143 ↗
77. 10.1016/j.jconrel.2014.03.05010.1016/j.jconrel.2014.03.050 ↗
78. 10.1111/j.1470-8744.1996.tb00361.x10.1111/j.1470-8744.1996.tb00361.x ↗
79. 10.1021/nn404853z10.1021/nn404853z ↗
80. 10.1517/1742524100361063310.1517/17425241003610633 ↗
81. 10.1021/acs.nanolett.7b0526310.1021/acs.nanolett.7b05263 ↗
82. 10.4049/jimmunol.173.2.144410.4049/jimmunol.173.2.1444 ↗
83. 10.1097/CJI.0b013e318218760010.1097/CJI.0b013e3182187600 ↗
84. 10.1021/acsnano.6b0647710.1021/acsnano.6b06477 ↗
85. 10.1016/j.apsb.2018.12.00910.1016/j.apsb.2018.12.009 ↗
86. 10.1016/j.colsurfb.2019.11075510.1016/j.colsurfb.2019.110755 ↗
87. 10.2147/IJN.S28863610.2147/IJN.S288636 ↗
88. 10.1016/j.biomaterials.2017.07.02610.1016/j.biomaterials.2017.07.026 ↗
89. 10.1002/pat.453810.1002/pat.4538 ↗
90. 10.1002/smll.20160062410.1002/smll.201600624 ↗
91. 10.1039/D0BM01164A10.1039/D0BM01164A ↗
92. 10.1016/j.trecan.2020.09.00310.1016/j.trecan.2020.09.003 ↗
93. 10.3390/pharmaceutics1212117110.3390/pharmaceutics12121171 ↗
94. 10.1152/ajpcell.00228.201310.1152/ajpcell.00228.2013 ↗
95. 10.1038/nri85510.1038/nri855 ↗
96. 10.1016/j.addr.2012.07.00210.1016/j.addr.2012.07.002 ↗
97. 10.7150/thno.3085310.7150/thno.30853 ↗
98. 10.1126/sciadv.aax794610.1126/sciadv.aax7946 ↗
99. 10.1021/acs.langmuir.0c0023610.1021/acs.langmuir.0c00236 ↗
100. 10.1039/D0NR03041D10.1039/D0NR03041D ↗